Thiel-backed Azitra raises $3M for skin microbiome R&D; Crushed by clinical failure, Aviragen launches strategic review
→ Farmington, CT-based Azitra has raised close to $3 million in a Series A designed to fuel its research on microbiome therapies for the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
